Terms: = Thyroid cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
87 results:
1. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
3. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer.
Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z
Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775
[TBL] [Abstract] [Full Text] [Related]
4. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
5. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-myc-mediated glycolysis.
Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
[TBL] [Abstract] [Full Text] [Related]
6. Methylation-Mediated Silencing of ATF3 Promotes thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
7. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
8. TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance.
Qiu Y; Wang X; Sun Y; Du YE; Yin G; Luo H; Wen S; Lang L; Liu M; Tang X
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166727. PubMed ID: 37137433
[TBL] [Abstract] [Full Text] [Related]
9. Small molecule Z363 co-regulates TAF10 and myc via the E3 ligase TRIP12 to suppress tumour growth.
Xiong Y; Wang L; Xu S; Fu B; Che Y; Zaky MY; Tian R; Yao R; Guo D; Sha Z; Lin F; Lin X; Wu H
Clin Transl Med; 2023 Jan; 13(1):e1153. PubMed ID: 36639831
[TBL] [Abstract] [Full Text] [Related]
10. mycBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients.
Wang G; Miao C; Mo L; Kahlert UD; Wu J; Ou M; Huang R; Feng R; Pang W; Shi W
Front Immunol; 2022; 13():1048503. PubMed ID: 36582246
[TBL] [Abstract] [Full Text] [Related]
11. Disulfiram/Copper Suppresses cancer Stem Cell Activity in Differentiated thyroid cancer Cells by Inhibiting BMI1 Expression.
Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
[TBL] [Abstract] [Full Text] [Related]
12. Effects of Ruxolitinib and Calcitriol Combination treatment on Various Molecular Subtypes of Breast cancer.
Schneider J; Jeon YW; Suh YJ; Lim ST
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269680
[TBL] [Abstract] [Full Text] [Related]
13. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
[TBL] [Abstract] [Full Text] [Related]
14. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract] [Full Text] [Related]
15. Diallyl trisulphide, a H
Zhang L; Xu S; Cheng X; Zheng J; Wang Y; Wu J; Wang X; Wu L; Yu H; Bao J
Phytother Res; 2021 Jun; 35(6):3428-3443. PubMed ID: 33751676
[TBL] [Abstract] [Full Text] [Related]
16. circRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis.
Zhang X; Yang H; Jia Y; Xu Z; Zhang L; Sun M; Fu J
BMC Mol Cell Biol; 2021 Jan; 22(1):6. PubMed ID: 33472586
[TBL] [Abstract] [Full Text] [Related]
17. TTF-1 and c-myc-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for treatment Selection.
Miyagawa-Hayashino A; Okada S; Takeda-Miyata N; Takashima Y; Yamada T; Takemura Y; Uchino J; Inoue M; Takayama K; Konishi E
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):313-320. PubMed ID: 33031101
[TBL] [Abstract] [Full Text] [Related]
18. A Multicenter Retrospective Study of 58 Patients With Primary thyroid Diffuse Large B Cell Lymphoma.
Yi J; Yi P; Wang W; Wang H; Wang X; Luo H; Fan P
Front Endocrinol (Lausanne); 2020; 11():542. PubMed ID: 32982962
[No Abstract] [Full Text] [Related]
19. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
20. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
[TBL] [Abstract] [Full Text] [Related]
[Next]
